Rapamycin Suppresses Angiogenesis and Lymphangiogenesis in Melanoma by Downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 Expression
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s205160
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
Informa UK Limited